⚠ Disclaimer: This report is generated using AI tools and is for informational purposes only. It does not constitute investment advice. Please consult a registered financial advisor before making any investment decisions.
WOCKPHARMA - Technical Analysis with Chart Patterns & Indicators
Back to ListTechnical Rating: 3.4
| Stock Code | WOCKPHARMA | Market Cap | 19,805 Cr. | Current Price | 1,219 ₹ | High / Low | 1,870 ₹ |
| Stock P/E | 98.5 | Book Value | 178 ₹ | Dividend Yield | 0.00 % | ROCE | 4.40 % |
| ROE | -0.53 % | Face Value | 5.00 ₹ | DMA 50 | 1,339 ₹ | DMA 200 | 1,380 ₹ |
| Chg in FII Hold | -0.10 % | Chg in DII Hold | -0.45 % | PAT Qtr | 38.0 Cr. | PAT Prev Qtr | 54.0 Cr. |
| RSI | 35.0 | MACD | -44.0 | Volume | 4,41,631 | Avg Vol 1Wk | 5,94,732 |
| Low price | 1,154 ₹ | High price | 1,870 ₹ | PEG Ratio | 4.08 | Debt to equity | 0.76 |
| 52w Index | 8.96 % | Qtr Profit Var | 273 % | EPS | 11.8 ₹ | Industry PE | 27.6 |
📊 Technical Analysis
- Chart Patterns: Price is below both 50 DMA (₹1,339) and 200 DMA (₹1,380), showing weakness.
- RSI: At 35.0, near oversold territory, suggesting possible support but still bearish.
- MACD: Strongly negative (-44.0), confirming bearish momentum.
- Bollinger Bands: Price near lower band, indicating selling pressure.
- Volume Trends: Current volume (4.41L) below 1-week average (5.94L), showing reduced participation.
📈 Momentum & Signals
- Short-term Momentum: Bearish, with strong downward bias.
- Support Zone: ₹1,154 – ₹1,219 (recent low and current price).
- Resistance Zone: ₹1,339 – ₹1,380 (DMA levels).
- Optimal Entry: Around ₹1,154–₹1,219 if support holds.
- Optimal Exit: Near ₹1,339–₹1,380 unless breakout occurs.
- Trend Status: Reversing downward after prolonged weakness.
✅ Positive
- EPS at ₹11.8, showing earnings base.
- Quarterly profit variation (+273%) indicates strong rebound compared to prior losses.
- PEG ratio of 4.08, suggesting growth potential despite valuation concerns.
⚠️ Limitation
- High P/E (98.5) compared to industry average (27.6).
- ROCE (4.40%) and ROE (-0.53%) weak, showing poor efficiency.
- Debt-to-equity at 0.76, relatively high leverage.
📉 Company Negative News
- Quarterly PAT declined from ₹54 Cr. to ₹38 Cr.
- FII holding decreased (-0.10%) and DII holding decreased (-0.45%), showing reduced investor confidence.
📈 Company Positive News
- Quarterly profit variation (+273%) highlights recovery momentum despite decline in absolute PAT.
🏭 Industry
- Industry P/E at 27.6, much lower than company’s 98.5, suggesting sector is cheaper.
- Sector growth modest with 8.96% index gain in 52 weeks.
🔎 Conclusion
WOCKPHARMA is showing bearish technical signals, trading below both 50 DMA and 200 DMA with weak RSI and strongly negative MACD. Fundamentals remain weak with high leverage, poor efficiency, and stretched valuations. Short-term traders should watch ₹1,154–₹1,219 as support and ₹1,339–₹1,380 as resistance. The stock is currently reversing downward, and sustained movement above ₹1,380 would be needed to signal recovery.